Biologic agents have become more common to treat patients with psoriasis, but concerns about their effect on pregnancy and lactation often preclude this treatment during these time periods. During the past decade, we have gained a much better understanding of the course of psoriasis during pregnancy and the safety of the use of biologic agents during pregnancy and lactation. Under certain circumstances, biologic agents can be considered appropriate treatment options for patients who are pregnant or lactating
Psoriasis is an inflammatory disease that affects women in their reproductive years. Other similar d...
Cutaneous sarcoidosis is a common presentation for patients with sarcoidosis. Rarely, patients can p...
Psoriasis is a common, chronic inflammatory disease with a multifactorial pathogenesis. Mean age at ...
Biologic agents have revolutionized the treatment of psoriasis, and the increasing use of these agen...
Psoriasis is a common, chronic, autoimmune inflammatory disease that affects a substantial number of...
Psoriasis is a chronic inflammatory disease that affects primarily the skin and joints, with a world...
Psoriasis is a chronic immune-mediated inflammatory disease that affects about 2%-4% of the populati...
Psoriasis is a chronic immunologic disease involving inflammation that can target internal organs, t...
Data regarding the use of biologic therapies for psoriasis during pregnancy are scarce with even mor...
IMPORTANCE: Prospective data are limited on pregnancy outcomes among women with psoriasis who may be...
The Australasian Psoriasis Collaboration has reviewed the evidence for managing moderate to severe p...
Megha K Trivedi,1,2 Alexandra R Vaughn,3 Jenny E Murase1,4 1Department of Dermatology, University o...
Psoriasis and hidradenitis suppurativa (HS) are chronic inflammatory skin diseases that frequently ...
We performed a retrospective study including 307 psoriatic women of childbearing age treated with bi...
Objective To develop evidence- and experience-based recommendations for the management of psoriasis ...
Psoriasis is an inflammatory disease that affects women in their reproductive years. Other similar d...
Cutaneous sarcoidosis is a common presentation for patients with sarcoidosis. Rarely, patients can p...
Psoriasis is a common, chronic inflammatory disease with a multifactorial pathogenesis. Mean age at ...
Biologic agents have revolutionized the treatment of psoriasis, and the increasing use of these agen...
Psoriasis is a common, chronic, autoimmune inflammatory disease that affects a substantial number of...
Psoriasis is a chronic inflammatory disease that affects primarily the skin and joints, with a world...
Psoriasis is a chronic immune-mediated inflammatory disease that affects about 2%-4% of the populati...
Psoriasis is a chronic immunologic disease involving inflammation that can target internal organs, t...
Data regarding the use of biologic therapies for psoriasis during pregnancy are scarce with even mor...
IMPORTANCE: Prospective data are limited on pregnancy outcomes among women with psoriasis who may be...
The Australasian Psoriasis Collaboration has reviewed the evidence for managing moderate to severe p...
Megha K Trivedi,1,2 Alexandra R Vaughn,3 Jenny E Murase1,4 1Department of Dermatology, University o...
Psoriasis and hidradenitis suppurativa (HS) are chronic inflammatory skin diseases that frequently ...
We performed a retrospective study including 307 psoriatic women of childbearing age treated with bi...
Objective To develop evidence- and experience-based recommendations for the management of psoriasis ...
Psoriasis is an inflammatory disease that affects women in their reproductive years. Other similar d...
Cutaneous sarcoidosis is a common presentation for patients with sarcoidosis. Rarely, patients can p...
Psoriasis is a common, chronic inflammatory disease with a multifactorial pathogenesis. Mean age at ...